8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) July 24, 2008

Interleukin Genetics, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-32715	94-3123681
(Commission File Number)	(IRS Employer Identification No.)
135 Beaver Street Waltham, MA	02452
(Address of Principal Executive Offices)	(Zip Code)
(781) 398-0700
(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.

Item 5.02(b)

Effective as of July 24, 2008, Dianne E. Bennett resigned from the Board of Directors of Interleukin Genetics, Inc. (the “Company”).

Item 5.02(d)

(1)           Effective as of July 24, 2008, Glenn S. Armstrong, Ph.D. was elected to fill the vacancy created by Ms. Bennett’s resignation, pursuant to the provisions of the Company’s Restated Certificate of Incorporation, by the directors remaining in office that were elected by the holder of the Company’s Series A Convertible Preferred Stock.  In addition, Dr. Armstrong will serve on the Board of Directors’ Compensation Committee and Nominating Committee.  There are no related party transactions between the Company and Dr. Armstrong reportable under Item 404(a) of Regulation S-K.

Glenn S. Armstrong is Vice President of Corporate/Business Innovations for Alticor Inc. and leads Alticor’s Growth Through Innovation initiative.  He joined Alticor in July 2007 from the Wm. Wrigley Jr. Company, where he was senior director and lead scientist of the company’s New Ventures Group & Mergers and Acquisitions.  Armstrong is the former founder and president of Armstrong Sargent Group, Inc., a marketing, research and development, and technology assessment consulting firm.  He also held marketing, innovation and product development, and science research positions with Whirlpool Corp., Quaker Oats Company, and General Mills, Inc.  Armstrong earned a Bachelor of Science degree in botany from Eastern Illinois University in Charleston, Ill.  He received a Master of Science degree in food science, and a Ph.D. in food science from Purdue University in West Lafayette, Ind.  He also studied with a research team as a research chemist at Massachusetts Institute of Technology.

(2)           Effective as of July 24, 2008, Mary E. Chowning was elected to fill the newly created directorship resulting from the increase in the Company’s Board of Directors disclosed under Item 5.03 below.  In addition, Ms. Chowning will serve on the Board of Directors’ Audit Committee and Nominating Committee.  There are no related party transactions between the Company and Ms. Chowning reportable under Item 404(a) of Regulation S-K, other than Ms. Chowning’s interest in the letter agreement described immediately below.

Pursuant to a letter agreement, the Company agreed to compensate Ms. Chowning for her service on the Board of Directors as follows: (i) payment of $14,000 per twelve-month period of Board service, payable in four equal quarterly installments; (ii) payment of $1,500 per meeting attended in person or by teleconference; (iii) grant of a non-qualified stock option upon commencement of her Board service, pursuant to the Company’s 2004 Employee, Director and Consultant Stock Plan, to purchase 15,000 shares of the Company’s Common Stock at an exercise price equal to the closing price of the Common Stock as reported on the American Stock Exchange on the grant date, to vest over four years in equal annual installments on the anniversaries of the grant date.  In addition, the Company agreed to pay Ms. Chowning an additional $7,500 per twelve-month period for her service as the Chair of the Audit Committee of the Board of Directors.

2

Mary E. Chowning served as Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 28, 2003 to July 5, 2006.  Chowning served as an Executive Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 5, 2006 to March 3, 2008 and also served its Principal Accounting Officer from July 28, 2003 to March 3, 2008. Prior to X-Rite, she Co-founded the Wind River group of companies and served as its Managing Member, as well as its Chief Financial Officer for four years.  Ms. Chowning began her career with Arthur Andersen LLP and spent 14 years in Public Accounting where she served in various positions of increasing responsibility with public and private clients in manufacturing, consumer products, technology and various service industries. She was made a Partner in the firm in 1996. Ms. Chowning is currently a member of the Board of Directors of Fincor Holdings, Inc., a privately held medical malpractice insurance and consulting company. Ms. Chowning is a graduate of the University of California where she holds a Bachelor of Arts in Economics. She is a Certified Public Accountant in California and a member of the American Institute of Certified Public Accountants.

(3)           Effective as of July 24, 2008, the Company’s Chief Executive Officer, Lewis H. Bender, was elected to fill the newly created directorship resulting from the increase in the Company’s Board of Directors disclosed under Item 5.03 below.  It is not currently expected that Mr. Bender will serve on any of the committees of the Board of Directors.  There are no related party transactions between the Company and Ms. Chowning reportable under Item 404(a) of Regulation S-K, other than Mr. Bender’s interest in his employment agreement described under Item 1.01 of the Current Report on Form 8-K filed January 23, 2008.

A copy of the Company’s press release announcing the appointments of Ms. Chowning, Dr. Armstrong and Mr. Bender, dated July 28, 2008 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 5.03  AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

Effective as of July 24, 2008, the Board of Directors of the Company amended and restated the Company’s bylaws to, among other things, amend certain voting thresholds of the Board of Directors in light of the increase in the number of directors from five to seven, clarify the manner in which stockholder proposals and nominations for director should be brought to the attention of the Company, and streamline the provisions relating to the duties and responsibilities of the committees of the Board of Directors.

A copy of the Company’s Amended and Restated Bylaws, reflecting the changes adopted by the Board of Directors as of July 24, 2008, is attached hereto as Exhibit 3.1 and incorporated herein by reference.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(d)	Exhibit.
	3.1	Amended and Restated Bylaws of the Company dated July 24, 2008.
	99.1	Press Release dated July 28, 2008.

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Interleukin Genetics, Inc.
	(Registrant)
Date: July 28, 2008	/s/ ELIOT M. LURIER
	Eliot M. Lurier
	Chief Financial Officer
	(Signature)

4

EX-3.1

Exhibit 3.1

AMENDED AND RESTATED BYLAWS OF

INTERLEUKIN GENETICS, INC. (a Delaware Corporation)

DATED JULY 24, 2008

OFFICES

1. Registered Office. The Corporation shall at all times maintain a registered office in the State of Delaware.

2. Other Offices. The Corporation may also have offices at such other places within or outside of the State of Delaware as the Board of Directors (the “Board of Directors” or the “Board”) shall from time to time appoint or the business of the Corporation require.

CAPITAL STOCK

3. Issuance of Stock. The Board of Directors may authorize the issuance of the capital stock of the Corporation at such times, for such consideration, and on such terms and conditions as the Board may deem advisable, subject to any restrictions and provisions of law, the Certificate of Incorporation, as amended and restated from time to time (the “Certificate of Incorporation”), of the Corporation or any other provisions of these Amended and Restated Bylaws (“Bylaws”).

4. Certificated and Uncertificated Stock. The shares of the Corporation may be certificated or uncertificated, as provided by the corporation laws of the State of Delaware, and shall be entered in the books of the Corporation and registered as they are issued.  Any certificates representing shares of stock shall be in such form as the Board of Directors shall prescribe, certifying the number and class of shares of the stock owned by the stockholder.  Any certificates issued to a stockholder of the Corporation shall bear the name of the Corporation and shall be signed by the Chairman of the Board of Directors, or the Chief Executive Officer or the President or a Vice President, and by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary.

Any or all of the signatures on the certificates may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if the signatory were such officer, transfer agent or registrar at the date of issue. The certificates shall otherwise be in such form as may be determined by the Board of Directors, shall be issued in numerical order, shall be entered in the books of the Corporation as they are issued and shall exhibit the holder’s name and number of shares.

5.  Transf ers of Stock. The shares of the capital stock of the Corporation are transferable only on the books of the Corporation upon surrender, in the case of certificated shares, of the certificates therefor properly endorsed for transfer, or otherwise properly assigned, and upon the presentation of such evidences of ownership of the shares and validity of the assignment as the Corporation may require.

6.  Registered Ownership. The Corporation shall be entitled to treat the person in whose name any share of stock is registered as the owner thereof for

1

purposes of dividends and other distributions in the course of business or in the course of recapitalization, consolidation, merger, reorganization, liquidation, or otherwise, and for the purpose of votes, approvals and consents by stockholders, and for the purpose of notices to stockholders, and for all other purposes whatsoever, and shall not be bound to recognize any equitable or other claim to or interest in such share on the part of any other person, whether or not the Corporation shall have notice thereof, save as expressly required by the laws of the State of Delaware.

7.  Transfer Agent. The Board of Directors may appoint one or more transfer agents and registrars, and may require certificates for shares to bear the signature of such transfer agent(s) and registrar(s).

8.  Lost, Stolen or Destroyed Certificates. Upon the presentation to the Corporation of a proper affidavit attesting the loss, destruction or mutilation of any certificate for shares of stock of the Corporation, the Board of Directors may direct the issuance of a new certificate or uncertificated shares in lieu of and to replace the certificate so alleged to be lost, destroyed or mutilated. The Board of Directors may require as a condition precedent to the issuance of a ne w certificate or uncertificated shares any or all of the following: (a) additional evidence of the loss, destruction or mutilation claimed; (b) advertisement of the loss in such manner as the Board of Directors may direct or approve; (c) a bond or agreement of indemnity, in such form and amount and with such surety (or without surety) as the Board of Directors may direct or approve; and (d) the order or approval of a court.

STOCKHOLDERS AND MEETINGS OF STOCKHOLDERS

9.   ;Location. All meetings of stockholders shall be held at such place within or outside of the State of Delaware as shall be fixed by the Board of Directors and stated in the notice of meeting.

10.  Date. The Annual Meeting of Stockholders of the Corporation shall be held on such date and at such time as is fixed by the Board of Directors and stated in the notice of meeting. Directors shall be elected in accordance with the provisions of the Certificate of Incorporation and these Bylaws and such other business shall be transacted as may properly come before the meeting.

11.  Adjournment. The Annual Meeting of Stockholders may be adjourned by the presiding officer of the meeting for any reason (including, if the presiding officer determines that it would be in the best interests of the Corporation to extend the period of time for the solicitation of proxies) from time to time and place to place until the presiding officer shall determine that the business to be conducted at the meeting is completed, which determination shall be conclusive.

12.  Stockholder Proposals and Nominations for Director. At an Annual Meeting of the Stockholders, only such business shall be conducted as shall have been properly brought before the me eting. To be properly brought before an Annual Meeting, business must be (a) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors, (b) otherwise properly brought before the meeting by or at the direction of the Board of Directors or (c) otherwise properly brought before the meeting by a stockholder of the Corporation. For business to be properly brought before an annual meeting by a stockholder, including stockholder proposals and stockholder nominations for director, the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation. To be timely, a stockholder’s notice must be delivered to or mailed and received by the Secretary at the

2

principal executive offices of the Corporation, not less than 60 days nor more than 90 days prior to the first anniversary date of the annual meeting that immediately precedes the notice; provided, however, that in the event that the date of the first annual meeting following the notice is more than 30 days prior to or 60 days after the first anniversary date of the annual meeting that immediately precedes the notice, to be timely, notice by the stockholder must be delivered not earlier than 90 days prior to such annual meeting and not later than the later of (x) 60 days prior to such annual meeting or (y) 10 days after the date that the meeting is first disclosed to the public. Notwithstanding the foregoing, for a stockholder proposal or nomination for direct or to be considered for inclusion in the Corporation’s proxy statement relating to its next annual meeting, stockholder proposals must be received by the Secretary no later than 120 days prior to the date of the first anniversary of the filing date of the proxy statement for the immediately preceding annual meeting. Notwithstanding the foregoing, if an existing director is not standing for reelection to a directorship that is the subject of an election at such meeting, then a stockholder may make a nomination with respect to such directorship at anytime not later than the close of business on the tenth day following the date on which a written statement setting forth the fact that such directorship is to be elected and the name of the nominee proposed by the Board of Directors is first mailed to stockholders.

Other than in the case of stockholder nominations for director, a stockholder’s notice to the Secretary shall set forth as to each matter the stockholder proposes to bring before the annual meeting (a) a brief description of the business desired to be brought before the annual meeting, (b) the name and address, as they appear on the Corporation’s books, of the stockholder proposing such proposal, (c) the class and number of shares of the Corporation that are beneficially owned by the stockholder and (d) any material interest of the stockholder in such business. In the case of stockholder nominations for director, a stockholder’s notice to the Secretary shall set forth: (a) the name and address of the stockholder who intends to make the nomination and of the person or persons to be nominated; (b) a representation that the stockholder is a holder of record of stock of the Corporation entitled to vote at s uch meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice; (c) a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nomination or nominations are to be made by the stockholder; (d) such other information regarding each nominee proposed by such stockholder as would be required to be included in a proxy statement filed pursuant to the Securities Exchange Act of 1934 and the rules and regulations thereunder (or any subsequent provisions replacing such Act, rules or regulations); and (e) the consent of each nominee to serve as a director of the Corporation if so elected.

In addition, if the stockholder’s ownership of shares of the Corporation, as set forth in the notice, is solely beneficial, documentary evidence of such ownership must accompany the notice. Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with the procedures set forth in this Section 12. The presiding officer of an annual meeting shall, if the facts warrant, determine and declare to the meeting that any business that was not properly brought before the meeting is out of order and shall not be transacted at the meeting.

13.  Special Meetings. A special meeting of stockholders may only be called by the Chairman of the Board, the Chief Executive Officer or the Board of Directors pursuant to a resolution adopted by a majority of the directors then in office. The notice of every special meeting of stockholders shall state the

3

purpose for which it is called. At any special meeting of stockholders, only such business shall be conducted as shall be provided for in the resolution or resolutions calling the special meeting or, where no such resolution or resolutions have been adopted, only such business shall be conducted as shall be provided in the notice to stockholders of the special meeting. Any special meeting of stockholders may be adjourned by the presiding officer of the meeting for any reason (including, if the presiding officer determines that it would be in the best interests of the Corporation to extend the period of time for the solicitation of proxies) from time to time and from place to place until the presiding officer shall determine that the business to be conducted at the meeting is completed, which determination shall be conclusive.

14.  Timing of Notice. Written notice of each meeting of stockholders shall be mailed to each stockholder of record at his last address as it appears on the books of the Corporation at least ten days prior to the date of the meeting.

15.  Record Date. The Board of Directors shall have the power to close the stock transfer books of the Corporation for a period not more than sixty nor less than ten days preceding the date of any m eeting of stockholders, or the date for payment of any dividend, or the date for the allotment of rights, or the date when any reclassification or change or conversion or exchange of capital stock shall go into effect; provided, however, that in lieu of closing the stock transfer books as aforesaid, the Board of Directors may fix in advance a date not more than sixty nor less than ten days preceding the date of any meeting of stockholders, or the date for any payment of dividends, or the date for allotment of rights, or the date when any reclassification or change or conversion or exchange of capital stock shall go into effect, as a record date for the determination of the stockholders entitled to vote at any such meeting or entitled to receive payment of any such dividend or to any such allotment of rights, or to exercise the rights in respect of any such reclassification, change, conversion or exchange of capital stock, and in such cases only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to vote at such meeting, or to receive payment of such dividend, or to receive such allotment of rights, or to exercise such rights or to participate in the effect of any such transaction, as the case may be, notwithstanding any transfer of any stock on the books of the Corporation after any such record date fixed as aforesaid. This Bylaw shall in no way affect the rights of a stockholder and his transferee or transferor as between themselves.

16.  Quorum. The holders of a majority of the outstanding shares of stock of the Corporation having voting power with respect to a subject matter (excluding shares held by the Corporation for its own account) present or represented by proxy shall constitute a quorum at the meet ing of stockholders for the transaction of business with respect to such subject matter. In the absence of a quorum with respect to a particular subject matter, the presiding officer of the meeting shall have power to adjourn the meeting from time to time, without notice other than an announcement at the meeting, until a quorum is present with respect to that subject matter. If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. At such adjourned meeting, any business may be transacted that might have been transacted at the meeting as originally notified.

17.  Vot ing Requirements. When a quorum is present or represented at any meeting of stockholders, the affirmative vote of the holders of a majority of the shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall be the act of the stockholders in all

4

matters, unless the matter is one upon which, by express provision of the corporation laws of the State of Delaware, of the Certificate of Incorporation or of these Bylaws, a different vote is required, in which case such express provision shall govern and control the decision of that matter. Directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy and entitled to vote on the election of directors.

18.  Proxies. Every stockholder having the right to vote sha ll be entitled to vote in person, or by proxy appointed by an instrument in writing subscribed by such stockholder (which for purposes of this paragraph may include a signature and form of proxy pursuant to a facsimile or telegraphic form of proxy or any other instruments acceptable to the Inspector of Elections), bearing a date not more than three years prior to voting, unless such instrument provides for a longer period, and filed with the Secretary of the Corporation before, or at the time of, the meeting. If such instrument shall designate two or more persons to act as proxies, unless such instrument shall provide to the contrary, a majority of such persons present at any meeting at which their powers thereunder are to be exercised shall have and may exercise all the powers of voting thereby conferred, or if only one be present, then such powers may be exercised by that one; or, if an even number attend and a majority do not agree on any particular issue, each proxy so attending shall be entitled to exer cise such powers in respect of the same portion of the shares as he is of the proxies representing such shares.

19.  Votes Per Share. Unless otherwise provided by the Certificate of Incorporation or by the corporation laws of the State of Delaware, each stockholder of the Corporation shall, at every meeting of stockholders, be entitled to one vote in person or by proxy for each share of capital stock of the Corporation registered in his name.

20.  Authority of Stockholder to Vote. Any other corporation owning voting shares in this Corporation may vote the same by its President or by proxy appointed by him, unless some other person shall be appointed to vote such shares by resolution of the Board of Directors of such stockholder corporation. A partnership holding shares of this Corporation may vote such shares by any general partner or by proxy appointed by any general partner.

21.  Authority of Stockholder Representatives. Shares standing in the name of a deceased person may be voted by the executor or administrator of such deceased person, either in person or by proxy. Shares standing in the name of a guardian, conservator or trustee may be voted by such fiduciary, either in person or by proxy, but no such fiduciary sh all be entitled to vote shares held in such fiduciary capacity without a transfer of such shares into the name of such fiduciary. Shares standing in the name of a receiver may be voted by such receiver. A stockholder whose shares are pledged shall be entitled to vote such shares, unless in the transfer by the pledgor on the books of the Corporation, the pledgor has expressly empowered the pledgee to vote thereon, in which case only the pledgee, or his proxy, may represent the stock and vote thereon.

22.  Organization and Conduct of Business. The order of business and all other matters of procedure at every meeting of the stockholders may be determined by the presiding officer of the meeting, who shall be the Chairman of the Board, or the Chief Executive Officer, or in the absence of both of them such other officer of the Corporation as designated by the Board. The presiding officer of the meeting shall have all the powers and authority vested in a presiding officer by law or practice without restriction, including, without limitation, the authority, in order to conduct an orderly meeting, to impose reasonable limits on the amount of time at the meeting taken up in remarks by

5

any one stockholder and to declare any business not properly brought before the meeting to be out of order.

23.  Inspector of Elections. The Board shall appoint one or more Inspectors of Elections to serve at every meeting of the stockholders.

DIRECTORS AN D MEETINGS OF DIRECTORS

24.  Role of Board. The business of the Corporation shall be managed by a Board of Directors, who shall exercise all the powers of the Corporation not reserved to or conferred on the stockholders by statute, the Certificate of Incorporation or the Bylaws of the Corporation.

25.  Number of Directors. Except as otherwise fixed pursuant to the provisions of the Certificate of Incorporation relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation to elect additional directors under specified circumstances, the number of directors shall be as fixed from time to time by resolution of the Board adopted by the affirmative vote of at least a majority of the directors then in office, provided the number shall be not less than the minimum or more than the maximum number permitted by the Certificate of Incorporation, provided further that if no such minimum or maximum number is stated in the Certificate of Incorporation the number shall not be less than three nor more than 12. The directors, other than those who may be elected by the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, shall be divided into three classes as nearly equal in number as possible, with the term of office of one class expiring each year. Directors shall be assigned to each class in accordance with a resolution or resolutions of the Board o f Directors. The term of office of each director shall expire at the third Annual Meeting after election of the class to which such director belongs. During the intervals between Annual Meetings of Stockholders, any vacancy occurring in the Board of Directors caused by resignation, removal, death or other incapacity, and any newly-created directorships resulting from an increase in the number of directors, shall be filled by a majority vote of the directors then in office, whether or not a quorum. Each director chosen to fill a vacancy shall hold office for the unexpired term in respect of which such vacancy occurs. Each director chosen to fill a newly-created directorship shall hold office until the next election of the class for which such director shall have been chosen.

26.  Nominations for Director. Subject to the rights of holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, nominations for the election of directors may be made by the Board of Directors or a committee appointed by the Board of Directors or by any stockholder entitled to vote in the election of directors generally (see Section 12 of these Bylaws). The presiding officer of the meeting may refuse to acknowledge the nomination of any person not made in compliance with the procedures contained in these Bylaws.

27.  Removal and Resignation. Any director may be removed from office as a director at any time, but only for cause (as set forth in the C ertificate of Incorporation), by the affirmative vote of stockholders of record holding a majority of the outstanding shares of stock of the Corporation entitled to vote in elections of directors generally.  Any director may resign at any time upon notice given in writing or by electronic transmission to the Corporation at its principal place of business or to the Chairman of the Board, Chief Executive Officer, President or Secretary.  Such resignation shall be effective upon receipt

6

unless it is specified to be effective at some other time or upon the happening of some other event.

28.  Notice of Meetings. Regular meetings of the Board of Directors shall be held at such times and at such place or places as the directors shall, from time to time, determine at a prior meeting. Special meetings of the Board may be called by the Chairman of the Board, Chief Executive Officer or President of the Corporation or upon the written request of any two directors. Special meetings shall be held at the office of the Corporation or at such place as is stated in the notice of the meeting. Notices of regular and special meetings shall be given by mail at least two days before the meeting or by email, telephone or facsimile at least 24 hours before the meeting. Notices may be waived and attendance at a regular or special meeting constitutes a waiver of notice. Notices need not include any statement of the purpose of the meeting.

29.  Conduct of Business. When all of the directors shall be present at any meeting, however called or notified, they may act upon any business that might lawfully be transacted at regular meetings or at special meetings duly called, and action taken at such meetings shall be as valid and binding as if legally called and notified. Directors may participate in meetings of the Board by means of conference telephone or similar communications equipment to the full extent and with the same effect as authorized and permitted by Delaware law.

30.  Quorum and Action by Written Consent. Five directors, at least three of whom shall have been elected by the holders of the Corporation’s Series A Preferred Stock, provided that the Series A Preferred Stock is outstanding, shall constitute a quorum for the transaction of business, and the acts of a majority of the directors present at any meeting at which there is a quorum present shall be the acts of the Board; provided, however, that the directors may act in such other manner, with or without a meeting, as ma y be permitted by the laws of the State of Delaware and provided further, that if all of the directors shall consent in writing to any action taken by the Corporation, such action shall be as valid as though it had been authorized at a meeting of the Board.

31.  Compensation and Reimbursement. Directors shall receive such compensation and reimbursement for expenses for attendance at meetings of the Board or of committees thereof and such other compensation as shall be fixed by a majority of the Board.

COMMITTEES OF DIRECTORS

32.  Organization, Required Committees, Quorum, Notice and Conduct of Business. The Board of Directors shall establish an Audit Committee and a Compensation Committee, and may establish an Executive Committee, a Nominating Committee and such other committees as may be established by resolution of a majority of the Board. Each of such committees shall consist of at least three directors. Members of committees of the Board of Directors shall be elected annually by vote of a majority of the Board. Presence of a majority of the committee members (not counting any ex-officio nonvoting members) shall constitute a quorum. Committees may act by majority vote of the voting members present at a meeting. Each of such committees shall have and may exercise such of the powers of the Board of Directors in the management of the business and affairs of the Corporation as may be provided in these Bylaws, by resolution of the Board of Directors or pursuant to such committees’ written charters. Each of such committees may authorize the seal of the Corporation to be affixed to any document or instrument. The Board of Directors may designate one or more directors as alternate members of any such committee, who may replace any absent

7

or disqualified member at any meeting of such committee. Meetings of committees may be called by any member of a committee by written, email, facsimile or telephonic notice to all members of the committee and shall be held at such time and place as shall be stated in the notice of meeting. Any member of a committee may participate in any meeting by means of conference telephone or similar communications equipment. In the absence or disqualification of a member of any committee the member or members thereof present at any meeting and not disqualified from voting, whether or not constituting a quorum may, if deemed advisable, unanimously appoint another member of the Board to act at the meeting in the place of the disqualified or absent member. Each committee may fix such othe r rules and procedures governing conduct of meetings as it shall deem appropriate.

33.  Executive Committee. The Executive Committee of the Board of Directors, if one is established, shall consist of not less than three directors. The Executive Committee shall have and exercise the authority of the Board of Directors between meetings of the Board, subject to such limitations and restrictions required by Delaware law or as the Board may impose in a resolution duly adopted by the Board.

34.  Audit Committee. The Audit Committee shall consist of not less than three directors, at least one of whom shall have been elected by the holders of the Corporation’s Series A Preferred Stock, provided that the Series A Preferred Stock is outstanding. On behalf of the Board, the Audit Committee shall carry out the duties and responsibilities set forth in the committee’s written charter.

35.  Compensation Committee. The Compensation Committee shall consist of not less than three directors, at least one of whom shall have been elected by the holders of the Corporation’s Series A Preferred Stock, provided that the Series A Preferred Stock is outstanding. On behalf of the Board, the Compensation Comm ittee shall carry out the duties and responsibilities set forth in the committee’s written charter.

36.  Nominating Committee. The Nominating Committee, if one is established, shall consist of not less than three directors, at least one of whom shall have been elected by the holders of the Corporation’s Series A Preferred Stock, provided that the Series A Preferred Stock is outstanding.  On behalf of the Board, the Nominating Committee shall carry out the duties and responsibilities set forth in the committee’s written charter.

37.  Action by Written Consent. Any action required or permitted to be taken at any meeting of any committee of the Board of Directors may be taken without a meeting if a consent in writing, setting forth the action so taken, is signed by all of the members of such committee.

OFFICERS

38.  Required and Other Officers. The Board of Directors shall elect a Chief Executive Officer, President and a Secretary, and m ay elect a Chairman of the Board, a Treasurer, one or more vice presidents, including one or more Senior Vice Presidents and Executive Vice Presidents and a Chief Financial Officer, a General Counsel, a Controller, one or more assistant secretaries and assistant treasurers, and such other officers as the Board of Directors shall deem appropriate. The Chairman of the Board shall be a director of the Corporation. Other officers need not be directors. One individual may be elected to and hold multiple offices.

8

39.  Appointment, Removal and Scope of Duties. Officers of the Corporation shall hold office until their successors are chosen and qualified or until their earlier resignation or removal. Any officer, agent or employee may be removed at any time, with or without cause, by the Board but such removal shall be without prejudice to the contractual rights, if any, of the person so removed. Election or appointment of an officer or agent shall not of itself create contract rights. Vacancy occurring in any office or position at any time may be filled by the Board. All officers, agents and employees of the Corporation shall respectively have such authority and perform such duties in the conduct and management of the Corporation as may be delegated by the Bo ard of Directors or by these Bylaws.

40.  Compensation. Officers shall receive such compensation as may from time to time be determined by the Board of Directors. Agents and employees shall receive such compensation as may from time to time be determined by the Chief Executive Officer.

41.  Chief Executive Officer. The Chairman of the Board, if one is elected, may preside, or may direct that the Chief Executive Officer or President so preside, at all meetings of the stockholders a nd at all meetings of the directors. In the absence of the Chairman of the Board, or if no Chairman of the Board is elected, the Chief Executive Officer or President shall so preside. If the Board of Directors shall elect a person to be the Chairman of the Board and shall designate such person the Chief Executive Officer of the Corporation, the Chairman of the Board shall supervise and direct the operations of the business of the Corporation in accordance with the policies determined by the Board of Directors.  If the Board of Directors shall elect a person to be the Chairman of the Board and shall designate some other person the Chief Executive Officer of the Corporation, the Chief Executive Officer of the Corporation shall supervise and direct the operations of the business of the Corporation in accordance with the policies determined by the Board of Directors.

42.  President. Unless the Board of Directors shall have elected a Chairman of the Board of Directors or shall have designated some other person the Chief Executive Officer of the Corporation, the President shall be the Chief Executive Officer of the Corporation, supervising and directing the operations of the business of the Corporation in accordance with the policies determined by the Board of Directors. If the Board of Directors shall have elected a Chairman of the Board and designated such person as a Chief Executive Officer or shall have elected some other person the Chief Executive Officer of the Corporation, the President shall be the Chief Operating Officer of the Corporation and shall be responsible for the general supervision and control of the business and the affairs of the Corporation subject to the directions of the Chairman of the Board, Chief Executive Officer and the Board of Directors. If the Board of Directors shall have elected a person Chairman of the Board and shall designate such person the Chief Executive Officer of the Corporation or shall have elected some other person the Chief Executive Officer, the President, in the absence or incapacity of such Chairman of the Board or Chief Executive Officer, shall perform the duties of that office.

43.  Vice President. A Vice President, if one is elected, in the absence or incapacity of the President, shall perform the duties of the President. If there be more than one Vice President, the Board of Directors shall designate the Vice President who is to perform the duties of the President in the event of his absence or incapacity. Each Vice President shall hav e such other duties and authority as shall be assigned by the Chief Executive Officer or may be delegated by the Board of Directors. The Executive Vice President and Chief Financial Officer, if one is elected, shall be responsible for and direct,

9

either directly or indirectly through any Treasurer, Controller or Director of Data Processing of the Corporation, all treasury, accounting, cost and budgeting, and data collection functions. Such person will report directly to the Chief Executive Officer or President, as the case may be, with a report and policy relationship to the Chairman of the Board and the Board of Directors.

44.  Secretary. The Secretary shall attend all meetings of the Board of Directors and all meetings of stockholders and shall record all votes and minutes from all proceedings in a book to be kept for that purpose. The Secretary shall keep in safe custody the seal of the Corporation and affix the same to any instrument requiring it, and when so affixed, it shall be attested by his signature or by the signature of the Treasurer or an Assistant Secretary; provided, however, that the affixing of the seal of the Corporation to any document or instrument specifically shall not be required in order for such document or instrument to be binding on or the official act of the Corporation, and the signature of any authorized officer, without the seal of the Corporation, shall be sufficient for such purposes. The Secretary shall perform such other duties and have such other authorities as are delegated to him by the Board of Directors.

45.  Treasurer. The Treasurer, if one is elected, shall be responsible for the care and custody of all funds and other financial assets, taxes, corporate debt, order entry and sales invoicing including credit memos, credit and collection of accounts receivable, cash receipts, and the banking and insurance functions of the Corporation. The Treasurer shall report directly to and perform such other duties as shall be assigned by the Executive Vice President and Chief Financial Officer, if one is elected, or otherwise the Chief Executive Officer or President.

46.  Controller. The Controller, if one is elected, shall be responsible for the installation and supervision of all general accounting rec ords of the Corporation, preparation of financial statements and the annual and operating budgets and profit plans, continuous audit of accounts and records of the Corporation, preparation and interpretation of statistical records and reports, taking and costing of all physical inventories and administering the inventory levels, supervision of accounts payable and cash disbursements function and hourly and salary payrolls. The Controller shall report directly to and perform such other functions as shall be assigned such person by the Executive Vice President and Chief Financial Officer, if one is elected, or otherwise the Chief Executive Officer or President.

47.  Bond. The Board of Directors of the Corporation may require any officer, agent or employee to give bond for the faithful discharge of his duty and for the protection of the Corporation, in such sum and with such surety as the Board deems advisable.

BANKING, CHECKS AND OTHER INSTRUMENTS

48.  Designation of Bank. The Board of Directors shall by resolution designate the bank or banks in which the funds of the Corporation shall be deposited, and such funds shall be deposited in the name of the Corporation and shall be subject to checks drawn as authorized by resolution of the Board of Directors.

49.  Authorized Persons for Conducting Business with Bank. The Board of Directors may in any instance designate the officers and agents who shall have authority to execute any contract, conveyance, or other instrument on behalf of the Corporation; or may ratify or confirm any execution. When the execution of

10

any instrument has been authorized without specification of the executing officer or agents, the Chairman of the Board, if designated as the Chief Executive Officer of the Corporation, Chief Executive Officer, President or any Vice President, and the Secretary or Assistant Secretary or Treasurer or Assistant Treasurer may execute the same in the name and on behalf of the Corporation and may affix the corporate seal thereto; provided, however, that the affixing of the seal of the Corporation to any document or instrument specifically shall not be required in order for such document or instrument to be binding on or the official act of the Corporation, and the signature of any authorized officer, without the seal of the Corporation, shall be sufficient for such purposes.

FISCAL YEAR

50.  The fiscal year of the Corporation shall begin on the first day of January and end on the thirty-first day of December.

BOOKS AND RECORDS

51.  The proper officers and agents of the Corporation shall keep and maintain such books, records and accounts of the Corporation’s business and affairs and such stock ledgers and lists of stockholders as the Board of Directors shall deem advisable and as shall be required by the laws of the State of Delaware or other states or jurisdictions empowered to impose such requirements.

INDEMNIFICATION

52.  Each director or officer of the Corporation or a subsidiary of the Corporation who was or is made a party or is threatened to be made a party to or is involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a “proceeding”), by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Corporation or a subsidiary of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereaf ter be amended (the “DGCL”)(but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment) against all expenses, (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators. The right to indemnification conferred in this Section shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition; provided, however, that, if the DGCL requires, the payment of such expenses incurred by a director or officer in his or her capacity as a director or offic er (and not in any other capacity in which service was or is rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such

11

director or officer is not entitled to be indemnified under the applicable provisions of the DGCL. The Corporation may, by action of its Board of Directors, provide indemnification to employees and agents of the Corporation or a subsidiary of the Corporation with the same scope and effect as the foregoing indemnification of directors and officers.

53.  The indemnification and advancement of expenses provided in paragraph 52 of these Bylaws shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any agreement, vote of stockholders, vote of disinterested directors, insurance arrangement or otherwise, both as to action in his or her official capacity and as to action in another capacity.

AMENDMENTS

54.  By Board or Stockholders. Except as otherwise provided in the Certificate of Incorporation, these Bylaws may be altered, amended or repealed and new Bylaws may be adopted at any regular or special meeting of the Board of Directors; or at any regular or special meeting of the stockholders. Subject to applicable provisions of the Certificate of Incorporation, in the case where the Board of Directors may take such action, it may do so by the vote of two-thirds of those directors then in office. Subject to applicable provisions of the Certificate of Incorporation, the stockholders may make new Bylaws, or adopt, alter, amend, or repeal Bylaws adopted by either the stockholders or the Board of Directors by the affirmative vote of the holders of not less than two-thirds of the voting power of all of the then outstanding shares of capital stock of the Corporation then entitled to vote generally in the election of directors.

12

< font size="2" face="Times New Roman" style="font-size:10.0pt;">

EX-99.1

Exhibit 99.1

Interleukin Genetics Expands its Board of Directors

Mary Chowning, Glenn Armstrong, Ph.D., and CEO Lewis Bender added to the Board

Waltham, MA — July 28, 2008 — Interleukin Genetics, Inc., (AMEX:ILI), today announced that it has expanded its Board of Directors from five to seven and approved related corporate governance amendments, including the amendment of its bylaws.  In connection with the changes, Interleukin Genetics was able to add three new directors to the Board, Mary E. Chowning, Glenn S. Armstrong, Ph.D., and Chief Executive Officer Lewis H. Bender.  Ms. Chowning and Mr. Bender join the Board as Common Stock directors and Dr. Armstrong joins the Board as a Series A Preferred Stock director. Dianne Bennett, a current Series A Preferred Stock director, resigned effective with the new appointments.  Ms. Chowning has also agreed to serve as the Chairperson of the Audit Committee of the Board.

Mary E. Chowning served as Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 28, 2003 to July 5, 2006.  Ms. Chowning served as an Executive Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 5, 2006 to March 3, 2008 and also served as its Principal Accounting Officer from July 28, 2003 to March 3, 2008. Prior to X-Rite, she co-founded the Wind River group of companies and served as its Managing Member, as well as its Chief Financial Officer for four years.  Ms. Chowning began her career with Arthur Andersen LLP and spent 14 years in Public Accounting where she served in various positions of increasing responsibility with public and private clients in manufacturing, consumer products, technology and various service industries. She was made a Partner in the firm in 1996. Ms. Chowning is currently a member of the Board of Directors of Fincor Holdings, Inc., a privately held medical malpractice insurance and consulting company. Ms. Chowning is a graduate of the University of California where she holds a Bachelor of Arts in Economics. She is a Certified Public Accountant in California and a member of the American Institute of Certified Public Accountants.

“Mary’s strong financial background, as well as her public company and corporate governance experience, will be assets to our Board and, in particular, our Audit Committee,” commented James Weaver, Chairman of Interleukin Genetics.

Glenn S. Armstrong, Ph.D., is Vice President of Corporate/Business Innovations for Alticor Inc. and leads Alticor’s Growth Through Innovation initiative.  He joined Alticor in July 2007 from the Wm. Wrigley Jr. Company, where he was Senior Director and lead scientist of the company’s New Ventures Group & Mergers and Acquisitions.  Dr. Armstrong is the former founder and president of Armstrong Sargent Group, Inc., a marketing, research and development, and technology assessment consulting firm.  He also held marketing, innovation and product development, and science research positions with Whirlpool Corp., Quaker Oats Company, and General Mills, Inc.  Dr. Armstrong earned a Bachelor of Science degree in botany from Eastern Illinois University in Charleston, Illinois.  He received a Master of Science degree in food science, and a Ph.D. in food science from Purdue University in West Lafayette, Indiana.  He also studied with a research team as a research chemist at Massachusetts Institute of Technology.

Chairman Weaver remarked on the appointment of Dr. Armstrong, “Glenn has been spearheading innovation efforts in various capacities for years in leading multinational consumer products companies.  We are excited to leverage his rich experience in growing Interleukin Genetics’ business.”

The corporate governance amendments were the final step in the process of adding Lewis Bender, Chief Executive Officer of Interleukin Genetics, to its Board of Directors.  “We had contemplated that Lew would join the Board when he joined Interleukin Genetics as CEO and we are pleased that the process is now complete,” said Weaver.

About Interleukin Genetics

Interleukin Genetics, Inc. (AMEX:ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading

- more -

genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. The Company currently offers an array of Nutraceuticals and OTCeuticals®, including Ginkoba®, Ginsana® and Venastat® which are sold at the nation’s largest food, drug and mass retailers. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics and its ongoing programs, please visit www.ilgenetics.com.

Certain statements contained herein are “forward-looking” statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence, delays in product development, the performance of our commercial partners, the availability of adequate capital, the actions of our competitors and other competitive risks, and those risks and uncertainties described in our annual report, quarterly reports, and other documents filed with, or furnished to, the Securities and Exchange Commission. We disclaim any obligation or intention to update these forward-looking statements.

#   #   #

Contacts:

Media:
Lisa Rivero
LaVoie Group
978-745-4200 x106
lrivero@lavoiegroup.com

Investor Relations:
Melanie Friedman
Stern Investor Relations
212-362-1200
melanie@sternir.com